Honestly, I don't really understand all of this.
I get
Honestly, I don't really understand all of this.
I get that GNBT needs to pay ~$6 million to "Three Brothers LLC" according to the court ruling. Not sure still exactly why that is, but let's assume here that the judge knows what he is doing at least in this regard.
But how can that same court now order to give ALL OF GNBT's assets to these three brothers?
In the list that you present are single items included that are worth a multiple of the $6 mill. alone.
Take GNBT's part ownership in Olragen. During the May CC last year the Olaregen management team described a clear plan to roll out Excellegen with assumed double digit millions dollar revenues within the first year after they started this larger market introduction campaign.
With this information alone Olaregen is supposed to be worth a multiple of these assumed annual revenues, and thus GNBT's co-ownership should be worth at least 10 times the owed $6 mill.
Now let's look into NGIO. It has an assumed ready to be clinically tested Corona vaccine (current status unclear), the IP rights to its proprietary ii-key technology, several other developments in their pipeline (e.g. AE37) and a conservatively estimated stock market value of $500 mill.
Now let's look into Oral-lyn, the reason why I bought my first GNBT shares more than a decade ago. Back in 2005 it was assumed that the insulin market would be an industry with 2 billion dollar in annual revenues in the (back then) - near future, and Ana Gluskin was hoping to get at least a 10% share of that market with Oral-lyn. So this ready to be (again) "phase III" clinically tested product is supposed to be worth at least 10 times the $6 mill. that GNBT is supposed to pay to the 3 brothers.
So just from looking into these three items on the list that the court ordered to be given to Three Brothers to compensate them for their $6 mill. are worth several 10 times that amount. And even though it is yet unclear how much, the remaining items listed are supposedly be worth additional millions of dollars.
So HOW ON EARTH is it possible, not to mention JUST, that this court is giving away all of this company value, the value that belongs to us shareholders, to these Three Brothers?
Can somebody explain this to me?? I really don't get it.
Any hints or help to understand this, would be highly appreciated. And please refrain from "This is the Wild Wild West called the OTC" explanations, thank you!
3
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Popping Corks for Creativity: Decoy's New Chapter Stepping outside the vines and into the artistic limelight, Decoy Wines is shaking up the status quo. Announcing the launch of the Pour to What's Possible Grant, the brand is throwing down $10,000 to back creatives itching to make waves in entertainment. Now, doesn't that stand out? The Grit Behind the Grapes: Decoy's...
Continue Reading
Revving Up for Major Investor Conferences All eyes are on TETRA Technologies Inc. (NYSE:TTI) as they gear up to make splashy appearances at not one, but two high-profile investor conferences in New York. It's setting the stage for some potentially juicy conversations about where TTI, a player with deep roots in energy services, is heading in this whirlwind of an industry....
Continue Reading
Testing the Waters with Education Stake Talk about mixing oil and water. Scienjoy Holding Corporation, those tech-savvy folks from China's live streaming circles, have set their sights on education with a hefty 29.9% stake in Leader Education Limited. For HK$102.69 million, that’s about US$13.1 million, they’re jumping into an industry with a different flavor....
Continue Reading
Revamping Streetwear with PLAY Palm Angels and Pacsun In a move that's making waves from the fashion runways straight into the heart of youth culture, PLAY Palm Angels is swooping into Pacsun, and they’re not just strolling in—they’re parading with a 41-piece fashion collection. Not to mention, they've snagged Avani Gregg, a powerhouse cultural influencer, to strut...
Continue Reading
Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...
Continue Reading
Robo.ai's Financial Rocket Lift-off: Q2 Highlights Who would've thought a single acquisition could propel a company's revenue north of $180 million in just three months? Well, Robo.ai, with its recent grab of Quantum Core Capital (QC Capital), shattered that ceiling, showcasing what a savvy acquisition and a dash of tech wizardry can achieve. Strong Quarter, Stronger...
Continue Reading
Driving AI Adoption: A Shift Towards Human-Centric Learning McLean & Company has dropped an initiative that’s like laying fresh tracks for AI inclusion in businesses. Dubbed the Human-Centric AI Program, it’s a wake-up call to organizations struggling to shift AI from a novelty to a natural part of operations. This isn’t just about fiddling with AI tools; it’s...
Continue Reading
Financial Stress — The Silent Productivity Killer Down in the trenches of nine-to-five, it’s money that keeps stealing workers' peace of mind. The TELUS Mental Health Index shines a glaring spotlight on this, revealing that 58% of U.S. workers are most stressed by living costs. Now, that's a kicker when stacking it next to retirement or emergency savings. Those take...
Continue Reading
Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...
Continue Reading
Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....
Continue Reading
Top 5 Most Recently Viewed Articles
Introducing Super Fog Burzt: A Game Changer in Edibles Mfused has taken the edible cannabis industry by storm with the introduction of Super Fog Burzt, a fast-acting lemonade that is set to redefine how consumers experience cannabis edibles. Unlike traditional edibles, which can take time to kick in, Super Fog Burzt offers a quick-acting solution that allows users to...
Continue Reading
Target Hospitality's Bylaw Amendments and Their Implications Target Hospitality Corp. (NASDAQ: TH), known for providing lodging services to sectors such as energy and construction, has recently undertaken important amendments to its bylaws, aiming to strengthen governance and improve transparency for its stockholders. This proactive step was revealed in a recent SEC...
Continue Reading
Recent Funding Boost for ImmunOs Therapeutics AG ImmunOs Therapeutics AG, an innovative biopharmaceutical company with its own immune system modulating HLA-based technology, has successfully closed a Series C financing round, raising $11 million. This funding will help advance the development of cutting-edge cancer therapies and strengthen relationships with its...
Continue Reading
Goldman Sachs Adjusts Leadership in Banking & Markets Goldman Sachs is making notable changes within its banking and markets division, ushering in a new era of leadership as part of its latest strategic move. This adjustment reflects the firm’s commitment to evolve its managerial structure and improve operational efficiency. New Leadership Appointments As reported...
Continue Reading
Otis Worldwide Corporation CEO to Join Industry Leaders at Key Conference Otis Worldwide Corporation (NYSE: OTIS) is set to have its esteemed Chair, CEO, and President, Judy Marks, present at an influential conference hosted by Morgan Stanley. Well-known for her leadership and innovative vision, Judy Marks will participate in a fireside chat at the annual Laguna...
Continue Reading